What is the recommended schedule to switch a patient from 160 mg of methadone to Suboxone (Buprenorphine/Naloxone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Schedule for Switching from 160 mg Methadone to Suboxone Using Microdosing

For patients on high-dose methadone (160 mg), a microdosing strategy is recommended to transition to buprenorphine/naloxone (Suboxone) as it avoids precipitated withdrawal and allows for a more comfortable transition. 1

Microdosing Schedule

  • Day 1: Continue full methadone dose (160 mg) and add buprenorphine 0.5 mg once 1
  • Day 2: Continue full methadone dose and add buprenorphine 0.5 mg twice daily 1
  • Day 3: Continue full methadone dose and add buprenorphine 1 mg twice daily 1
  • Day 4: Reduce methadone by 25% (to 120 mg) and increase buprenorphine to 2 mg twice daily 1
  • Day 5: Reduce methadone by another 25% (to 80 mg) and increase buprenorphine to 4 mg twice daily 1
  • Day 6: Reduce methadone by another 25% (to 40 mg) and increase buprenorphine to 8 mg twice daily 1
  • Day 7: Discontinue methadone completely and increase buprenorphine to 12 mg twice daily (24 mg total daily dose) 2, 1

Monitoring and Adjustments

  • Monitor for withdrawal symptoms using the Clinical Opiate Withdrawal Score (COWS) throughout the transition 3
  • If withdrawal symptoms emerge (COWS >12), consider slowing the methadone taper or increasing the buprenorphine dose 3
  • Divided dosing (every 6-8 hours) may be more effective for pain management if that's a concern 2
  • The maximum recommended daily dose of buprenorphine is 24 mg for opioid use disorder treatment 2

Alternative Rapid Transition Methods (Hospital Setting Only)

For inpatient settings where rapid transition is necessary:

  • Naltrexone-precipitated withdrawal followed by buprenorphine "rescue" can achieve transition within hours 4, 3
  • This involves administering naltrexone (25 mg) to precipitate withdrawal, then administering buprenorphine/naloxone (16 mg/4 mg) approximately one hour later 3
  • This approach should only be used in controlled inpatient settings with close monitoring 4, 3

Important Considerations

  • Microdosing is preferred for high-dose methadone (>100 mg) as traditional methods require lengthy tapers 5
  • Traditional methods would require tapering methadone to 30-40 mg before initiating buprenorphine, which could take months at a safe rate of 3% reduction per week 6
  • Buprenorphine's high binding affinity for μ-opioid receptors may block effects of other opioids, making this transition challenging 2
  • Monitor for side effects including headache and constipation, which may be more pronounced at higher doses 2

Follow-up Care

  • Once stabilized on buprenorphine/naloxone, maintain on a single daily dose of 16-24 mg for opioid use disorder treatment 2
  • For patients with inadequate response, consider divided dosing or adjusting the maintenance dose within the 4-24 mg range 2
  • Close follow-up is essential during the first month after transition to ensure stability and adjust dosing as needed 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.